11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(
- Contribution to journal › Article
- 2008
-
Mark
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
(
- Contribution to journal › Scientific review
-
Mark
The role of SPINK1 in ETS rearrangement-negative prostate cancers
(
- Contribution to journal › Article
- 2007
-
Mark
Androgens and prostate cancer risk : A prospective study
(
- Contribution to journal › Article
-
Mark
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells
(
- Contribution to journal › Article
- 2006
-
Mark
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.
(
- Contribution to journal › Article
- 2005
-
Mark
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue
(
- Contribution to journal › Article
- 2004
-
Mark
Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men
(
- Contribution to journal › Article
-
Mark
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
(
- Contribution to journal › Article